Measuring Endocrine-Sensitive Endpoints in Infants
Author Information
Author(s): Tye E. Arbuckle, Russ Hauser, Shanna H. Swan, Catherine S. Mao, Matthew P. Longnecker, Katharina M. Main, Robin M. Whyatt, Pauline Mendola, Melissa Legrand, Joanne Rovet, Christine Till, Mike Wade, John Jarrell, Stephen Matthews, Guy Van Vliet, Carl-Gustaf Bornehag, Roger Mieusset
Hypothesis
What are the best methods for measuring endocrine-sensitive endpoints in infants?
Conclusion
The workshop participants recommended standardized methods for measuring endocrine-sensitive endpoints in infants to improve data consistency across studies.
Supporting Evidence
- Workshop participants discussed various methods for measuring infant endpoints.
- Standardized measurements are needed for comparing data across studies.
- Endocrine-sensitive measures are important for understanding health outcomes.
Takeaway
Scientists are trying to figure out the best ways to measure how chemicals affect babies' health, especially their growth and development.
Methodology
The workshop involved discussions among 20 investigators from North America and Europe about measuring endocrine-sensitive endpoints in infants.
Limitations
The validity of specific developmental endpoints as indicators of endocrine targets may require further investigation.
Participant Demographics
Participants included researchers from Canada, the United States, and Europe.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website